REFERENCES
- Gehrs K M, Anderson D H, Johnson L V, Hageman G S. Age-related macular degeneration—Emerging pathogenetic and therapeutic concepts. Ann Med 2006; 38(7)450–471
- Haddad S, Chen C A, Santangelo S L, Seddon J M. The genetics of age-related macular degeneration: A review of progress to date. Surv Ophthalmol 2006; 51(4)316–363
- Scholl H P, Fleckenstein M, Charbel I P, et al. An update on the genetics of age-related macular degeneration. Mol Vis 2007; 13: 196–205
- Haines J L, Hauser M A, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 308(5720)419–421
- Ross R J, Bojanowski C M, Wang J J, et al. The LOC387715 polymorphism and age-related macular degeneration: Replication in three case-control samples. Invest Ophthalmol Vis Sci 2007; 48(3)1128–1132
- Tan J S, Mitchell P, Kifley A, et al. Smoking and the long-term incidence of age-related macular degeneration: The Blue Mountains Eye Study. Arch Ophthalmol 2007; 125(8)1089–1095
- Thornton J, Edwards R, Mitchell P, et al. Smoking and age-related macular degeneration: A review of association. Eye 2005; 19(9)935–944
- Weale R. Smoking and age-related maculopathies. Lancet 2006; 368(9543)1235–1236
- Chakravarthy U, Stevenson M. Self-reported visual functioning and quality of life in age-related macular degeneration. Curr Opin Ophthalmol 2005; 16(3)179–183
- Mitchell J, Bradley C. Quality of life in age-related macular degeneration: A review of the literature. Health Qual Life Outcomes 2006; 4: 97
- Schmidt S, Hauser M A, Scott W K, et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 2006; 78(5)852–864
- Dasch B, Fuhs A, Meister A, et al. [Association between classic cardiovascular risk factors and age-related maculopathy (ARM) Results of the baseline examination of the Munster Aging and Retina Study (MARS).]. Ophthalmologe 2005; 102(11)1057–1063
- Dasch B, Fuhs A, Behrens T, et al. Inflammatory markers in age-related maculopathy: cross-sectional analysis from the Muenster Aging and Retina Study. Arch Ophthalmol 2005; 123(11)1501–1506
- Klaver C C, Assink J, van Leeuwen R, et al. Incidence and progression rates of age-related maculopathy: The Rotterdam Study. Invest Ophthalomol Vis Sci 2001; 42(10)2237–2241
- Rivera A, Fisher S A, Fritsche L G, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005; 14(21)3227–3236
- Seddon J M, Francis P J, George S, et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 2007; 297(16)1793–1800
- Schaumberg D A, Hankinson S E, Guo Q, et al. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol 2007; 125(1)55–62
- Mangione C M, Lee P P, Gutierrez P R, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001; 119(7)1050–1058
- Goetz S M, Stuck A E, Hirschi A, et al. [A multidimensional questionnaire as a component of preventive geriatric assessment: Comparison of self-assessment version with the interview version]. Soz Praventivmed 2000; 45(3)134–146
- Fuhs A, Dasch B, Behrens T, et al. [Visual function and quality of life in patients with age-related maculopathy:Results of the Munster Age and Retina Study (MARS)]. Klin Monatsbl Augenheilkd 2005; 222(8)649–654
- Frison L, Pocock S J. Repeated measures in clinical trials: Analysis using mean summary statistics and its implications for design. Stat Med 1992; 11(13)1685–704
- Leffondre K, Abrahamowicz M, Siemiatycki J, Rachet B. Modeling smoking history: A comparison of different approaches. Am J Epidemiol 2002; 156(9)813–823
- Neuner B, Wellmann J, Dasch B, et al. Modeling smoking history: A comparison of different approaches in the Mars study on age-related maculopathy. Ann Epidemiol 2007; 17(8)615–621
- SAS. Version 9.1. Cary, NCUSA 2000
- Despriet D D, Klaver C C, Witteman J C, et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 2006; 296(3)301–309
- Harrington J, Noble L M, Newman S P. Improving patients' communication with doctors: a systematic review of intervention studies. Patient Educ Couns 2004; 52(1)7–16